Sleep apnea treatment ranges from nightly breathing machines to implanted nerve stimulators to jaw-repositioning surgery, and the right option depends on severity, anatomy, and what you can realistically stick with long term. Continuous positive airway pressure (CPAP) remains the most widely prescribed approach, but it is far from the only one, and newer alternatives have matured enough that abandoning treatment because CPAP feels intolerable is no longer a reasonable default. The landscape has shifted meaningfully in the past decade, with drug therapies entering the picture for the first time and surgical techniques producing durable results that rival device-based options for selected patients.
CPAP and Why It Is Still the Standard
A CPAP machine delivers a continuous stream of pressurized air through a mask worn during sleep, splinting the upper airway open and preventing the repeated collapses that define obstructive sleep apnea. A Cochrane systematic review found that compared with oral appliances, CPAP reduced breathing disturbances by about eight additional events per hour and improved minimum blood-oxygen levels during sleep.1Cochrane Database of Systematic Reviews. Continuous positive airway pressure for obstructive sleep apnoea Engineering analyses confirm that the pressurized air supports airway walls against collapse without producing harmful shear forces on lung tissue, despite earlier concerns about that possibility.2PubMed. Airway stability in sleep apnea: Assessing continuous positive airway pressure efficiency
Beyond breathing metrics, CPAP produces measurable improvements in thinking and daily functioning. A longitudinal study of people with moderate-to-severe sleep apnea found that six months of CPAP use significantly improved episodic memory, sustained attention, working memory, and executive control, alongside reductions in daytime sleepiness and better mood.3PubMed Central. Impact of CPAP Therapy on Cognition and Fatigue in Patients with Moderate to Severe Sleep Apnea: A Longitudinal Observational Study On the cardiovascular side, evidence links CPAP use to lower systolic blood pressure, better heart-pumping function, and reduced platelet activation, all of which matter because untreated sleep apnea drives up cardiovascular risk.4PubMed Central. Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components
The Compliance Problem
CPAP works well when people actually use it, and that is its biggest weakness. Many patients reduce their usage or stop altogether because of mask discomfort, nasal congestion, dry mouth, or claustrophobia. One study found that patients who experienced side effects used their machines significantly less than those who did not.5PubMed Central. Compliance with CPAP therapy in patients with the sleep apnoea/hypopnoea syndrome Severity matters too. In a single-center analysis, long-term compliance among people with mild sleep apnea was only about 43%, compared with roughly 68% for those with moderate or severe disease.6PubMed Central. Factors Affecting Long-Term Compliance of CPAP Treatment–A Single Centre Experience This makes intuitive sense: if you feel dramatically better on the machine, you are more motivated to tolerate it. Research confirms that patients who notice the biggest improvements in sleepiness scores and oxygen levels tend to use their CPAP the most consistently.7PubMed. Predictive factors of long-term compliance with nasal continuous positive airway pressure treatment in sleep apnea syndrome
For people who find a single continuous pressure uncomfortable, bilevel positive airway pressure (BiPAP) machines offer two different pressure settings: a higher one when you breathe in and a lower one when you breathe out. This can feel more natural, and compliance tends to improve in people with pressure intolerance or coexisting heart or lung conditions.8PubMed Central. Selective indication for positive airway pressure (PAP) in sleep-related breathing disorders with obstruction Artificial intelligence is also being explored to personalize CPAP management, with models that identify patients at risk of dropping out and digital tools that intervene early to troubleshoot problems before someone gives up entirely.9PubMed. Rethinking CPAP Adherence with Artificial Intelligence
Oral Appliances as an Alternative to CPAP
Mandibular advancement devices (MADs) are custom-fitted dental appliances worn during sleep that push the lower jaw forward, widening the space behind the tongue and making airway collapse less likely. They are smaller and quieter than a CPAP machine, which is a genuine advantage for people who travel frequently or simply cannot tolerate a mask. A meta-analysis comparing the two found that CPAP reduces breathing disturbances more effectively than MADs, but on the measure that matters most to patients, daytime sleepiness, there was no meaningful difference between the two.10PubMed Central. Continuous Positive Airway Pressure vs Mandibular Advancement Devices in the Treatment of Obstructive Sleep Apnea: An Updated Systematic Review and Meta-Analysis
Blood pressure is one of the most important downstream consequences of untreated sleep apnea, and here the two treatments perform similarly. A JAMA network meta-analysis found that CPAP reduced systolic blood pressure by about 2.5 mmHg and MADs by about 2.1 mmHg compared with no treatment, with no statistically significant difference between them.11JAMA. CPAP vs Mandibular Advancement Devices and Blood Pressure in Patients With Obstructive Sleep Apnea: A Systematic Review and Meta-analysis The practical takeaway is that a MAD you wear every night will often outperform a CPAP that sits in a drawer. For mild-to-moderate sleep apnea, oral appliances are a legitimate first-line option, not a consolation prize.
Hypoglossal Nerve Stimulation
For people with moderate-to-severe obstructive sleep apnea who have tried CPAP and cannot use it, an implantable device that stimulates the hypoglossal nerve has become one of the more exciting options. The device, surgically placed under the skin of the chest with a lead running to the nerve that controls tongue movement, senses breathing effort and delivers mild electrical stimulation to push the tongue forward during sleep, keeping the airway open. A pivotal trial published in the New England Journal of Medicine found that the breathing-disturbance index dropped about 68% at 12 months, from a median of roughly 29 events per hour to 9.12PubMed. Upper-airway stimulation for obstructive sleep apnea When researchers temporarily turned the device off in a randomized withdrawal phase, disturbances shot back up to pre-treatment levels, confirming that the benefit was real and ongoing rather than some artifact of time passing.
Five-year follow-up data show the effect is durable. About three-quarters of patients maintained a strong response at five years, sleepiness scores normalized in most users, and serious device-related complications were uncommon, reported in about 6% of patients and mostly related to lead or device adjustments rather than dangerous events.13PubMed. Upper Airway Stimulation for Obstructive Sleep Apnea: 5-Year Outcomes The main limitation is eligibility. The device works best in people without a complete concentric pattern of airway collapse and without significant obesity, so a drug-induced sleep endoscopy is usually required before surgery to check whether the anatomy is suitable.
Traditional Surgical Approaches
Uvulopalatopharyngoplasty (UPPP) was for decades the most common sleep apnea surgery, involving removal or reshaping of tissue at the back of the throat. It still gets performed, but its results for moderate-to-severe cases are modest compared with more aggressive jaw surgery. A comparative study found that after adjusting for baseline severity, UPPP reduced breathing disturbances by about 19 events per hour, while maxillomandibular advancement (MMA), a procedure that moves both the upper and lower jaw forward, reduced them by about 41 events per hour.14PubMed Central. Comparative effectiveness of maxillomandibular advancement and uvulopalatopharyngoplasty for the treatment of moderate to severe obstructive sleep apnea
A 2020 meta-analysis of MMA outcomes confirmed substantial improvements: breathing disturbances dropped by roughly 42 events per hour on average, lowest oxygen levels improved, sleepiness scores fell substantially, and even body mass index showed a small decline.15PubMed. Maxillomandibular Advancement Safety and Effectiveness in Obstructive Sleep Apnea: Systematic Review and Meta-Analysis Network analysis has suggested that combining MMA with a soft-palate procedure that preserves the uvula may be the most effective surgical combination, though the evidence is still based on relatively small numbers.16PubMed. Preliminary comparison of the efficacy of several surgical treatments based on maxillomandibular advancement procedures in adult patients with obstructive sleep apnoea: a systematic review and network meta-analysis MMA is a significant procedure with a recovery measured in weeks, and it changes facial structure somewhat, so it tends to be reserved for severe cases that have failed other treatments. But for the right candidate, the results are among the most robust of any sleep apnea intervention.
Weight Loss and Bariatric Surgery
Excess weight is the single most modifiable risk factor for obstructive sleep apnea. Fat deposits around the upper airway narrow the breathing passage and increase its collapsibility, so losing weight can meaningfully reduce or even eliminate the condition. A meta-analysis of bariatric surgery patients found that the procedure cut breathing disturbances by about 19 events per hour on average, with roughly 65% of patients achieving full remission of their sleep apnea.17PubMed. Bariatric surgery and obstructive sleep apnea: a systematic review and meta-analysis An earlier meta-analysis in heavier surgical patients found even larger absolute drops, from an average baseline of about 55 events per hour down to about 16.18The American Journal of Medicine. Effects of Surgical Weight Loss on Measures of Obstructive Sleep Apnea: A Meta-Analysis
Not everyone with sleep apnea is overweight, and not everyone who is overweight wants surgery, so the picture is more nuanced than “lose weight, cure apnea.” But for those with obesity-driven disease, weight reduction can accomplish what no device or operation directed at the throat alone can: it addresses the underlying cause rather than compensating for it mechanically.
Emerging Drug Treatments
For most of sleep apnea’s history there was no pill you could take. That is beginning to change. GLP-1 receptor agonists, the same class of medications that includes tirzepatide and liraglutide, have shown significant reductions in breathing disturbances in clinical trials, primarily by driving weight loss. The SURMOUNT-OSA and SCALE Sleep Apnea trials demonstrated that the weight loss these drugs produce directly translates into lower apnea severity, and additional anti-inflammatory effects may contribute as well.19PubMed. Medications for Obstructive Sleep Apnea
A different pharmacological approach targets the muscles of the upper airway directly. A combination of atomoxetine and aroxybutynin (being studied under the name AD109) increases tongue-muscle tone during sleep, reducing airway collapse within hours of the first dose. This works independently of weight loss and could be an option for non-obese patients or anyone who cannot tolerate CPAP.20PubMed. Medications for Obstructive Sleep Apnea These drug treatments are still being refined, but they represent the first real pharmacotherapy pipeline in a condition that has historically had none.
Positional Therapy
Many people’s sleep apnea is substantially worse when they sleep on their back. Positional therapy uses wearable devices, specialized pillows, or even tennis balls sewn into the back of a shirt to keep you off your back during the night. A Cochrane review found that positional therapy reduced breathing disturbances by about seven events per hour compared with no treatment, and adherence was actually better than with CPAP: people used positional devices about two and a half hours more per night on average.21PubMed Central. Positional therapy for obstructive sleep apnoea CPAP still produced a greater reduction in breathing disturbances overall, so positional therapy works best for people whose apnea is predominantly position-dependent and mild to moderate in severity. For severe cases, positional therapy alone is usually not enough.
Myofunctional Therapy
Exercises that strengthen the tongue, soft palate, and throat muscles might sound too simple to make a difference, but the evidence for myofunctional therapy is surprisingly solid. A Cochrane review found that compared with sham exercises, oropharyngeal exercises probably reduce daytime sleepiness by a clinically meaningful amount and may cut breathing disturbances substantially.22PubMed Central. Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea A separate meta-analysis estimated that myofunctional therapy cuts breathing disturbances by roughly half in adults, with improvements in oxygen saturation, snoring, and sleepiness.23SLEEP. Myofunctional Therapy to Treat Obstructive Sleep Apnea: A Systematic Review and Meta-analysis A more recent meta-analysis similarly found significant improvements across breathing metrics, sleepiness, and sleep-related quality of life in adults who performed the exercises compared with controls.24PubMed. Orofacial Myofunctional Therapy for Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis
The exercises typically involve things like pressing the tongue firmly against the roof of the mouth, practicing specific swallowing techniques, and repeating vowel sounds in a prescribed pattern. They need to be done consistently, usually for several months, and the effect depends on actually keeping up the routine. Most sleep specialists view myofunctional therapy as an adjunct rather than a standalone fix for anything beyond mild cases, but it carries zero risk and can complement other treatments.
Nocturnal Oxygen Therapy
Supplemental oxygen delivered through a nasal cannula during sleep is sometimes considered for patients who cannot use CPAP and are not surgical candidates. The evidence here is genuinely mixed. A systematic review and meta-analysis found that nocturnal oxygen significantly reduced breathing disturbances by about 15 events per hour compared with sham air and modestly reduced blood pressure.25European Respiratory Review. Nocturnal oxygen therapy in obstructive sleep apnoea: a systematic review and meta-analysis It also reliably improves oxygen saturation levels during sleep.26PubMed. Treatment of hypoxemia in obstructive sleep apnea
The catch is that oxygen therapy can actually lengthen the duration of individual apnea and hypopnea episodes. One review found that while oxygen improved saturation, episodes of stopped or reduced breathing lasted longer in the oxygen group than in the placebo group.27PubMed Central. Obstructive sleep apnea and oxygen therapy: a systematic review of the literature and meta-analysis In other words, oxygen keeps your blood oxygen from crashing as severely, but it does not prevent the airway from collapsing. It treats the downstream consequence without addressing the upstream cause, which makes it a fallback rather than a primary treatment.
Central Sleep Apnea Is a Different Problem
Everything discussed so far applies to obstructive sleep apnea, where the airway physically collapses. Central sleep apnea is a distinct condition in which the brain intermittently stops sending the signal to breathe. Treatment for central sleep apnea can include adaptive servo-ventilation (ASV), a device that monitors breathing patterns and adjusts pressure support breath by breath to keep ventilation steady.28PubMed Central. Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure
ASV normalizes breathing disturbances effectively in most patients, but there is a critical safety caveat. In people with heart failure and significantly reduced pumping function (an ejection fraction of 45% or lower), ASV is actually recommended against because it was associated with worse outcomes in a major trial. For patients with better-preserved heart function or milder central apnea, ASV remains an option.29PubMed Central. Updated Adaptive Servo-Ventilation Recommendations for the 2012 AASM Guideline If you have been told you have central sleep apnea, the treatment path depends heavily on your heart function, and a specialist should be steering the decision.
Sleep Apnea in Children
Pediatric sleep apnea is most commonly caused by enlarged tonsils and adenoids, and the first-line treatment is usually adenotonsillectomy. But orthodontic interventions are gaining ground as a complementary approach, particularly rapid palatal expansion (RPE), a device cemented to the upper teeth that gradually widens the palate. A study found that children treated with RPE experienced an average adenoid volume decrease of about 17% and a tonsil volume decrease of nearly 39%, with some children seeing reductions as large as 50-75%.30PubMed Central. Impact of rapid palatal expansion on the size of adenoids and tonsils in children Sleep-disordered breathing scores improved significantly as well. When combined with adenotonsillectomy, myofunctional therapy, or mandibular advancement, rapid maxillary expansion can be especially effective for children with recurrent or residual apnea after initial treatment.31PubMed. The role of rapid maxillary expansion in pediatric obstructive sleep apnea: Efficacy, mechanism and multidisciplinary collaboration
Access to these treatments is not uniform. Research has shown that management of pediatric sleep apnea varies by insurance coverage, suggesting disparities in access to care that may leave some children with a greater disease burden than others.32PubMed Central. Sociodemographic disparities and healthcare utilization in pediatric obstructive sleep apnea management Orthodontic treatments in particular can fall outside standard medical insurance coverage, even when the clinical indication is airway-related rather than cosmetic.
Why Human Anatomy Makes Us Vulnerable
It is worth stepping back to ask why sleep apnea is so common in the first place. Part of the answer lies in evolutionary anatomy. The human upper airway evolved into a narrow, flexible tube partly to support the complex sound production required for speech. As the larynx descended, the tongue shifted back into the throat, and the soft palate shortened, we gained the ability to produce a remarkable range of sounds but lost the rigid, protected airway that most other mammals have.33Sleep Medicine. The Great Leap Forward: the anatomic basis for the acquisition of speech and obstructive sleep apnea The same flexible, collapsible pharynx that lets you speak is the one that closes up during sleep when muscle tone drops. Add obesity, a recessed jaw, or large tonsils to this already-compromised anatomy, and you have a recipe for obstruction. Sleep apnea is, in a sense, a side effect of being human.